✉news TechnologyTechnology first seen 10 d ago, last 10 d ago, peak #14

Single-Domain Antibodies Eyed as Building Blocks for New Drugs

Original: Single-Domain Antibodies as Building Blocks for Innovation

Science coverage is highlighting single-domain antibodies, the small antibody fragments found in camelids and sharks, as versatile building blocks for new therapies and research tools. Their tiny size, stability and ability to reach targets that conventional antibodies cannot make them attractive for drug developers and biotech innovators, and the discussion frames them as a foundation for future medical applications.

Why now: Growing biotech and pharma interest in single-domain antibodies as a platform for next-generation therapeutics is driving attention.

single-domain antibodiesTechnology Networksbiotechnology industry

Open on news →

Evidence

• Single-Domain Antibodies as Building Blocks for Innovation · Technology Networks
• Single-Domain Antibodies as Building Blocks for Innovation · Technology Networks

API: https://socialmediatrends-api.osmike.com/v1/trends/1364511